Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
Cash-Strapped Cryofocus Medtech Scrambles to Raise Funds With IPO
With only 128 million yuan in cash left in its coffers, the maker of innovative medical devices is desperate to secure fresh capital with a second stab at a Hong…
Medical Device Maker Venus Medtech Pumps Up Investors With Prospect of 2021 Profits
Company funds expansion through $400 million share sale as it targets U.S. and EU with growing pipeline of heart valve-replacement products Major Takeaways Venus Medtech’s recent $400 million equity fundraising…
RELATED ARTICLES
-
FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
2500.HK -
Yiren finds big returns in small-loan focus, even as headwinds swirl
YRD.US
- CHINA BULLETIN: Services, Trade Send Positive Signals
- CHINA BULLETIN: China Economy Off to Strong Start in 2024
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
